在全球药品市场逐渐回暖的背景下，2023年2月7日，十字路口的沃尔格林联合博姿（Walgreens Boots Alliance）宣布，已经完成对药品分销商Cencora股份的再次出售，共计套现约3亿美元。这一举动不仅令市场为之一振，也引发了各界对沃尔格林未来战略的热烈讨论。令人好奇的是，这笔交易究竟意味着什么？背后又隐藏着怎样的商业逻辑和资本运作？本篇文章将对此进行深入剖析。

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

2025年2月20日，保健护理产品经销商公司Cencora（COR）成交额为2.89亿美元，在当日美股中排第344名，成交额较昨日减少24.12%，当日成交量为118.85万。 Cencora（COR）于2025年2月20日跌0.80%，报243.46美元，该股过去5个交易日跌0.44%，整个2月跌4.23%，年初至今涨8.36%，过去52周涨4.28%。 *如果公司上市时间少于52周，则52周涨 ...

周三，Leerink Partners调整了对Cencora Inc (NYSE: COR)的财务展望，将目标股价从此前的287美元上调至301美元，同时维持"优于大市"评级。此次调整是基于Cencora 2025财年第一季度的出色业绩，公司再次超出预期并上调预测。根据InvestingPro数据显示，该股票目前接近52周高点261.25美元，年初至今回报率强劲达12%，分析表明基于其公允价值评估 ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

在公司内部方面，Cencora宣布两位资深董事会成员Richard W. Gochnauer和Kathleen W. Hyle退休。这一变动将使董事会规模从13人减少到11人。此外，Cencora已完成对Retina Consultants of America的收购，并上调了2025财年调整后每股收益指引。

CONSHOHOCKEN, Pa., February 07, 2025--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount ...

Shares of Cencora Inc. COR shed 1.28% to $243.59 Wednesday, on what proved to be an all-around grim trading session for the ...

AmerisourceBergen Corp. plans to settle a proposed class action by workers who say the pharmaceutical company’s retirement ...

Nearly 200 medications, including several oncology treatments, are now available through the program.

Get to know 2025 Diversity in Business honoree Ky’a Jackson, senior director of diversity, equity and inclusion at Cencora.